One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment
Tai‐Chung Tseng(National Taiwan University Hospital), Jia‐Horng Kao(National Taiwan University Hospital), George Papatheodoridis(National and Kapodistrian University of Athens), Chia‐Chi Wang(National Taiwan University), Mindie H. Nguyen(Stanford Medicine), Christopher K. Wong(University of California, Santa Cruz), Cheng‐Yuan Peng(China Medical University), Young‐Suk Lim(Asan Medical Center), Jian Zhang(Zhujiang Hospital), Jiayi Li(Northeastern University), Clifford Wong, Hsueh‐Chou Lai(China Medical University), Spyros I. Siakavellas(National and Kapodistrian University of Athens), Huy N. Trinh, Jonggi Choi(Ulsan College)
Cited by 11
Related Papers
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2021|708